Protocols
1 protocol(s) meet the specified criteria
Drug: INCAGN01876
Protocol No.TitleStatus
INCAGN1876-201A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 in Combination with Immune therapies in Subjects with Advanced or Metastatic MalignanciesOpen